ACCESS Newswire

Exosens

9.4.2024 09:03:39 CEST | ACCESS Newswire | Press release

Share
Exosens Adds Innovative Photon Counting System, LINCam, to Its Portfolio of Single Photon Sensitive Detectors

RODEN, NETHERLANDS / ACCESSWIRE / April 9, 2024 / Exosens is pleased to announce a partnership with Photonscore, a provider of instrumentation for time-correlated single photon imaging. Through this partnership, Exosens will distribute LINCam, an innovative camera system with picosecond time resolution through their Photonis-branded scientific imaging product portfolio.

To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.
Exosens & Photonscore Partnership

"We are delighted to partner with Photonscore and add LINCam to our scientific imaging solutions to our potential customers. LINCam is a breakthrough technology that enables fast and accurate time-resolved imaging for a variety of applications, such as biomedical research, material science, and quantum optics. LINCam complements our existing product line and combined will provide a unique value proposition." - Ulrich Laupper, President and Executive General Manager of the Exosens Ultimate Detection Business Unit.

LINCam is an easy-to-use, event-based camera that counts photons at high rate with the picosecond time resolution combined with accurate position information. Paired with a pulsed light source, LINCam can turn any conventional microscope into a powerful lifetime imager.

The partnership between Exosens and Photonscore is supported by Photonis, a brand of Exosens, which provides a crucial component of the camera: the high-time resolution position-sensitive MCP-PMT detector. Photonis has optimized the MCP-PMT which allows for the best properties for LINCam performance by providing high quantum efficiency and low dark rate photocathodes in a broad spectral range and also by implementing high linearity and high gain MCPs to increase the dynamic operational range. As a result of Exosens and Photonscore's close technical collaboration, the state-of-the-art high-time resolution single-photon camera LINCam becomes the optimal solution for widefield microscopy and other highly demanding applications.

"At Photonscore we are excited to start a productive partnership with Exosens. Their knowledge and experience in the field of photon detection gave us a big leap in the quality and capability of our system. In particular, the outstanding technology of Hi-QE photocathodes and high-performance MCPs enables us to bring LINCam to the applications where we did not dare enter into before." - Yury Prokazov, CEO, Photonscore GmbH

ABOUT PHOTONSCORE:

Photonscore GmbH specializes in simplifying single photon counting for its customers. The company's primary product, the LINCam, is a single photon counting camera with a 100% fill-factor and minimal noise. The company is serving leading universities and research institutes across the world, reflecting the broad applicability of its technologies. Photonscore's contributions to the field have been recognized with several awards. These include the 1st Prize in the Hugo-Junkers-Award 2017 for innovative applied research and nomination as a finalist in the German Innovation Award 2019. Photonscore is committed to advancing photon counting technology, striving to make it more accessible and effective for a wide range of applications.

ABOUT PHOTONIS:

Photonis is a leading brand of Exosens, a high-tech company with more than 85 years of experience in the innovation, development, manufacture, and sale of high-end electro-optical technologies used in the detection of ions, electrons, and photons. The Photonis brand portfolio offers photo-detection and low-light conditions imaging solutions for extremely demanding markets such as Defense & Security, Nuclear Safety, Life Science, and Industrial & Non-Destructive testing. Photonis is internationally recognized as a leading brand and a major innovator in its fields with production and R&D sites in Europe and North America.

For more information: exosens.com

Contact: scientificdetectors@exosens.com

Contact Information

Sales Manager
scientificdetectors@exosens.com
+31 50 501 8808

SOURCE: Photonis

To view this piece of content from stats.nwe.io, please give your consent at the top of this page.

View the original press release on newswire.com.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

QorusDocs Named LegalTech AI Platform of the Year and Ranked No. 1 Proposal Management Software17.11.2026 15:00:00 CET | Press release

BELLEVUE, WA / ACCESS Newswire / November 17, 2026 / QorusDocs, the pursuit intelligence platform trusted by dozens of Am Law 200 and Global 200 law firms, today announced it has been named LegalTech AI Platform of the Year in the seventh annual LegalTech Breakthrough Awards program and ranked the No. 1 proposal management solution by Info-Tech Research Group's SoftwareReviews, based on verified end-user reviews. The recognitions cap a year of rapid growth in legal for QorusDocs, which forecasts it will double its annual recurring revenue (ARR) from law firms in the next 12 months by adding more high-profile firms to its list of big law customers, which already includes DLA Piper, Baker McKenzie, Herbert Smith Freehills Kramer and Womble Bond Dickinson. Firms are moving AI beyond research and drafting and into business development, where a winning pitch depends on the best representative matters, strong attorney biographies and winning pitch strategies: knowledge general AI tools lack.

Freezz Italia Awarded ESA Contract for IRIS(2) Low-LEO Pre-Operational and De-Risk Activities17.11.2026 14:00:00 CET | Press release

CORTONA, IT / ACCESS Newswire / November 17, 2026 / Freezz Italia has been awarded a contract by the European Space Agency (ESA), as prime contractor leading a European industrial consortium, for the Consolidation Phase of the IRIS² Low-LEO Pre-Operational and De-Risk Activities, part of the ESA Programme Related to EU Secure Connectivity. The activity will further mature Friisat, Freezz's satellite system architecture conceived specifically for operation in Very Low Earth Orbit (VLEO) and designed for future broadband Direct-to-Device (D2D) connectivity within the 3GPP 5G/6G Non-Terrestrial Network (NTN) framework. Under this ESA contract, Freezz Italia will consolidate the mission and system architecture, adapting Friisat's existing commercial design to meet the requirements of an IRIS²-compatible solution, including future governmental broadband Direct-To-Device secure-connectivity services. The work will address the system and service concepts, architecture and interfaces, security

International Business Times UK Increases Programmatic Revenue by 30% with Opti Digital17.11.2026 11:00:00 CET | Press release

PARIS, FR / ACCESS Newswire / November 17, 2026 / Opti Digital, the leading AdTech company specialising in publisher revenue optimisation, today announced the results of its collaboration with International Business Times UK, an international digital news brand delivering business, markets, technology and current affairs coverage to a global readership. Operating in a fast-moving news environment, International Business Times UK continuously explores opportunities to increase the value of its digital audience while maintaining control over advertising quality and user experience. The publisher identified an opportunity to generate incremental revenue from its existing audience and inventory through a monetisation experience that could be tested progressively and scaled across a broader share of its inventory. "We were looking for ways to generate more value from our existing inventory, and the performance quickly demonstrated the potential of the new experience. It has become a meaning

OBI Pharma Signs Collaboration and License Agreement with Novartis16.11.2026 09:10:00 CET | Press release

TAIPEI, TW / ACCESS Newswire / November 16, 2026 / OBI Pharma, Inc. (4174.TWO) ("OBI") announced that it has entered into a Collaboration and License agreement with Novartis Pharma AG ("Novartis") to develop next generation Antibody-Drug-Conjugates (ADCs) with novel payloads, using OBI's suite of platform technologies. Under the terms of the agreement, Novartis will receive worldwide rights to OBI's related patents and know-how using its ADC platform technologies on an exclusive basis for selected, undisclosed Novartis payload classes. In parallel, under the collaboration OBI will evaluate novellinker approaches with the Novartis payloads. Novartis will further have the option to expand the agreement to include additional novel payload classes. This agreement marks an important milestone for OBI and underscores the value of its differentiated ADC technology platform. The agreement recognizes the potential of OBI's proprietary technologies, including GlycOBI®, EndoSymeOBI®, HYPrOBI®, an

Digi Power X Reports Q3 2026 Revenue Up 85% and AI Revenue Up Over 400% Compared to Q213.11.2026 13:30:00 CET | Press release

MIAMI, FL / ACCESS Newswire / November 13, 2026 / Digi Power X Inc. (Nasdaq:DGXX)(Cboe Canada:DGX) ("Digi Power X" or the "Company"), an AI data center infrastructure operator, today reported its financial and operating results for the third quarter ended September 30, 2026 (all amounts in U.S. dollars, unless otherwise indicated). The Company's quarterly report on Form 10-Q, which includes unaudited consolidated financial statements and management's discussion and analysis ("MD&A") for the quarter ended September 30, 2026, is being filed and made accessible under the Company's continuous disclosure profile on SEDAR+ at www.sedarplus.ca and will also be available on EDGAR at www.sec.gov/edgar. Third Quarter 2026 Highlights All amounts in U.S. dollars (millions) Revenue of $12.25 million, up 85% from the previously completed fiscal quarter and an increase of 50% compared to the quarter ended September 30, 2025; $119.6 million in cash, cash equivalents and digital currencies, $103.0 mill

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye